Research Applications
In Vitro vs In Vivo: What These Research Terms Mean
In vitro means in the lab; in vivo means in living systems. Here’s what each type of study tells researchers, why both…
Research Blog
In vitro means in the lab; in vivo means in living systems. Here’s what each type of study tells researchers, why both…
Dual agonist peptides activate two different receptor systems from a single molecule. Here’s how they work, how they differ from triple agonists,…
Half-life is the time it takes for half of a peptide to be eliminated from a system. Here’s how researchers measure it,…
Bioavailability measures how much of a peptide actually reaches its target. Here’s why most peptides can’t be taken orally, how different delivery…
The lock-and-key model describes how peptides bind to specific receptors based on molecular shape. Here’s how this model works, its limitations, and…
A receptor agonist is a molecule that binds to and activates a receptor, triggering a cellular response. Here’s how agonists work, how…
Published clinical studies have reported on GLP-3’s safety profile across multiple dose levels. Here’s what the data shows about tolerability, adverse events,…
The glucagon receptor is the third target in GLP-3’s triple agonist mechanism. Here’s what this receptor does, how it differs from GLP-1…
GIP (glucose-dependent insulinotropic polypeptide) receptor activation is one of GLP-3’s three targets. Here’s what the GIP receptor does and why it matters…
Pharmacokinetics describes how GLP-3 is absorbed, distributed, metabolized, and eliminated. Here’s a plain-English guide to what published PK data shows about this…
